IL6 and Lyme disease: When IL-6 promotor rs1800795 genotypes in Lyme borreliosis patients were addressed according to the group designations of secondary disease phenotypes, we found that especially group 1 (70%) and group 2 (66.7%) had elevated frequencies of heterozygous (G/C) genotypes.